您好,欢迎来到试剂仪器网! [登录] [免费注册]
试剂仪器网
位置:首页 > 产品库 > E3 ligase Ligand-Linker Conjugates 9
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
E3 ligase Ligand-Linker Conjugates 9
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
E3 ligase Ligand-Linker Conjugates 9图片
CAS NO:1835705-59-3
规格:98%
分子量:827.47
包装与价格:
包装价格(元)
100mg电议
500mg电议
1g电议
2g电议

产品介绍
E3ligaseLigand-LinkerConjugates9是用于PROTAC技术的化合物,其结合了E3连接酶配体和连接桥。
CAS:1835705-59-3
分子式:C40H63ClN4O10S
分子量:827.47
纯度:98%
存储:Store at -20°C

Background:

E3 ligase Ligand-Linker Conjugates 9 is a synthesized compound that incorporates an E3 ligase ligand and a linker used in PROTAC technology.


E3 ligase Ligand-Linker Conjugates 9 uses the VHL ligand[1]. The linker is 6-2-2-2-2-2-2. The linkers contain a mixture of hydrophobic and hydrophilic moieties to balance the hydrophobicity/hydrophilicity of the resulting hybrid compounds. PROTACs that induce the degradation of an oncogenic tyrosine kinase, BCR-ABL has been developed. E3 ligase Ligand-Linker Conjugates 9 can be attached to potent TKIs (bosutinib and dasatinib) that mediate the degradation of c-ABL and BCR-ABL by hijacking either CRBN or VHL E3 ubiquitin ligase [2].



[1]. US 20170121321 A1 [2]. Lai AC, et al. Modular PROTAC Design for the Degradation of Oncogenic BCR-ABL. Angew Chem Int Ed Engl. 2016 Jan 11;55(2):807-10.